New York State Common Retirement Fund’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-29,500
| Closed | -$1.11M | – | 3620 |
|
|
2021
Q1 | $1.11M | Hold |
29,500
| – | – | ﹤0.01% | 2079 |
|
|
2020
Q4 | $502K | Buy |
29,500
+16,700
| +130% | +$209K | ﹤0.01% | 2354 |
|
|
2020
Q3 | $60K | Hold |
12,800
| – | – | ﹤0.01% | 3099 |
|
|
2020
Q2 | $78K | Sell |
12,800
-15,300
| -54% | -$63K | ﹤0.01% | 3077 |
|
|
2020
Q1 | $64K | Hold |
28,100
| – | – | ﹤0.01% | 2925 |
|
|
2019
Q4 | $129K | Hold |
28,100
| – | – | ﹤0.01% | 2922 |
|
|
2019
Q3 | $109K | Hold |
28,100
| – | – | ﹤0.01% | 3006 |
|
|
2019
Q2 | $169K | Sell |
28,100
-7,900
| -22% | -$75.5K | ﹤0.01% | 2901 |
|
|
2019
Q1 | $482K | Hold |
36,000
| – | – | ﹤0.01% | 2330 |
|
|
2018
Q4 | $335K | Hold |
36,000
| – | – | ﹤0.01% | 2469 |
|
|
2018
Q3 | $501K | Hold |
36,000
| – | – | ﹤0.01% | 2408 |
|
|
2018
Q2 | $569K | Buy |
36,000
+5,400
| +18% | +$94.2K | ﹤0.01% | 2394 |
|
|
2018
Q1 | $526K | Hold |
30,600
| – | – | ﹤0.01% | 2327 |
|
|
2017
Q4 | $671K | Hold |
30,600
| – | – | ﹤0.01% | 2235 |
|
|
2017
Q3 | $1.25M | Buy |
30,600
+2,400
| +9% | +$75.3K | ﹤0.01% | 1893 |
|
|
2017
Q2 | $849K | Sell |
28,200
-3,710
| -12% | -$116K | ﹤0.01% | 2144 |
|
|
2017
Q1 | $1.15M | Sell |
31,910
-7,490
| -19% | -$330K | ﹤0.01% | 1951 |
|
|
2016
Q4 | $1.97M | Hold |
39,400
| – | – | ﹤0.01% | 1706 |
|
|
2016
Q3 | $2.07M | Buy |
39,400
+7,413
| +23% | +$354K | ﹤0.01% | 1635 |
|
|
2016
Q2 | $1.32M | Buy |
31,987
+8,587
| +37% | +$374K | ﹤0.01% | 1827 |
|
|
2016
Q1 | $951K | Buy |
23,400
+2,000
| +9% | +$68.7K | ﹤0.01% | 1978 |
|
|
2015
Q4 | $888K | Hold |
21,400
| – | – | ﹤0.01% | 2049 |
|
|
2015
Q3 | $329K | Sell |
21,400
-433
| -2% | -$9.31K | ﹤0.01% | 2513 |
|
|
2015
Q2 | $542K | Buy |
21,833
+847
| +4% | +$18.9K | ﹤0.01% | 2482 |
|
|
2015
Q1 | $480K | Buy |
+20,986
| New | +$530K | ﹤0.01% | 2040 |
|
New York State Common Retirement Fund's FPRX Position: Q2 2021 in Review
New York State Common Retirement Fund sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 29,500 shares — an estimated $1.11M sold.
New York State Common Retirement Fund first reported a position in FPRX in Q1 2015 and held it in 25 quarters. The position peaked at $2.07M in Q3 2016. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- New York State Common Retirement Fund reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- New York State Common Retirement Fund sold 29,500 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $1.11M.
- New York State Common Retirement Fund first reported a position in Five Prime Therapeutics, Inc. in Q1 2015 and held it in 25 quarters.
- New York State Common Retirement Fund's Five Prime Therapeutics, Inc. position peaked at $2.07M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on New York State Common Retirement Fund's 13F filing for Q2 2021, filed 2 Aug 2021.